UMass Medical School pharmacy experts to present at AMCP Nexus 2018

October 10, 2018

UMass Medical School experts in pharmacy will present on CAR-T outcomes, Medicaid payment models, specialty drug spending impact, and pediatric behavioral health medication safety at the Academy of Managed Care Pharmacy’s AMCP Nexus 2018 to be held Oct. 23-25 at the Orlando World Center Marriot in Florida.

Stephanie Tran, PharmD, clinical consultant pharmacist, and Therese Mulvey, MD, Drug Utilization Review Board member, will give a presentation titled, The CAR-T Carve Out: Reevaluating CAR-T Reimbursement and Long-Term Outcomes, as a part of the Drugs, Diseases and the Managed Care Impact track at 9:50 a.m. on Wednesday, Oct. 24. Their presentation discusses the CAR-T treatment process, reviews clinical evidence of its impact on patient outcomes, and discusses payer payment strategies.

Kimberly Lenz, PharmD, clinical pharmacy managerClinical Pharmacy Manager, will give a presentation as a part of the Preparing for the Next Generation of Care track titled, A Path Forward: Medicaid Accountable Care Organization Implementation, at 12:45 p.m. on Tuesday, Oct. 23. This presentation examines the early results stemming from ACOs, the value they bring as a new payment model, as well as the best practices and pitfalls of the ACO model. Lenz will also facilitate a round table on the same topic titled, Best Practices in Implementing a Medicaid Accountable Care Organization Model, at 4:45 p.m. on Wednesday, Oct. 24.

Nicole Trask, PharmD, clinical consultant pharmacist, will give a presentation on specialty drug spending titled, Bracing for Impact: Preparing for the 2020 Specialty Drug Spend, as a part of the Specialty Pharmacy Management: Keeping Up with Runaway Innovation track. This session is scheduled for Wednesday, Oct. 24 at 9:50 a.m. Trask will give an overview and discuss the impact of specialty drugs offered as well as several ground-breaking yet costly specialty medications that are in development. She will also discuss projections that predict a drastic increase in specialty drug spend, making it imperative for payers to plan ahead.

Andrew Coelho, PharmD, clinical consultant pharmacist, and Mike Angelini, MA, PharmD, BCPP, psychopharmacology consultant from MCPHS University, will give a presentation titled, A State Medicaid’s Experience Implementing an Oversight Program for Behavioral Health Medications in Publicly Insured Youth, as a part of the Drugs, Diseases and the Managed Care Impact track at 3 p.m. on Wednesday, Oct. 24. The presentation discusses efficacy and safety issues with behavioral medications, specifically among the pediatric population. The presenters will also look into strategies to monitor and manage behavioral health medications distribution and usage.

Full session information can be found at the AMCP Nexus 2018 website.

Related Links